Campbell & Co Investment Adviser’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Sell
21,084
-19,376
-48% -$1.14M 0.11% 296
2026
Q1
$1.55M Buy
40,460
+12,955
+47% +$410K 0.09% 354
2025
Q4
$600K Buy
27,505
+6,705
+32% +$139K 0.03% 753
2025
Q3
$447K Buy
20,800
+8,191
+65% +$184K 0.03% 778
2025
Q2
$323K Buy
+12,609
New +$369K 0.02% 931

Other funds holding ATEX

Campbell & Co Investment Adviser's ATEX Position: Q2 2026 in Review

Campbell & Co Investment Adviser reduced its Anterix (ATEX) stake by 48% in Q2 2026, selling an estimated $1.14M and leaving 21,084 shares worth $2.17M. The position accounts for 0.11% of the portfolio, ranked #296.

Campbell & Co Investment Adviser first reported a position in ATEX in Q2 2025 and has held it in 5 quarters since. 33 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Campbell & Co Investment Adviser held 21,084 shares of Anterix worth $2.17M as of Q2 2026.
  • Campbell & Co Investment Adviser sold 19,376 Anterix shares in Q2 2026, an estimated $1.14M.
  • Anterix made up 0.11% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #296 holding.
  • Campbell & Co Investment Adviser first reported a position in Anterix in Q2 2025 and has held it in 5 quarters since.
  • 33 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.